Proove Genomics
Proove Genomics is a leader in predictive health, utilizing advanced genetics and information technology to revolutionize medical decision-making. Their approach focuses on predicting and preventing health issues, thereby enhancing treatment outcomes and reducing healthcare costs. Proove's predictive healthcare model is supported by a vast clinical data bank, aiming to address major health challenges and reduce the leading causes of death.
Proove Genomics
What We Do
Published in Human Molecular Genetics, this product accounts for 96% of the population and correlates with sensitivity to experimental pain.
Published in Journal of Addiction Research and Therapy, it predicts patients with Opioid Use Disorder with 96.7% accuracy and 100% positive predictive value.
Assesses genotypic and phenotypic factors to classify patients' pain sensitivity levels, aiding clinicians in treatment and rehabilitation decisions.
Evaluates genotypic and phenotypic factors to classify patients' risk for medication-mediated side effects, helping clinicians prescribe safely.
Assesses genotypic and phenotypic factors to guide clinicians in making reliable treatment decisions, especially for poly-pharmacy patients.